Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervarix vs Gardasil Cross-neutralizing Capacity in Female Twins
NCT01914367Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Jun 2013
- Primary completion
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of human papillomavirus type 16 L1 capsid protein antigen, qHPV vaccine in human papillomavirus infection, sponsored by Ghent University Hospital. Started Jun 2013; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigenqHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01914367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914367.